Somatostatin and growth hormone regulation in cancer

This publication has 29 references indexed in Scilit:

• Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in Acromegaly
  Annals of Internal Medicine, 1990
• Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer
  Breast Cancer Research and Treatment, 1989
• Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut
  Annals of Internal Medicine, 1989
• Somatostatin and Octreotide: Literature Review and Description of Therapeutic Activity in Pancreatic Neoplasia
  Drug Intelligence & Clinical Pharmacy, 1988
• Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
  Proceedings of the National Academy of Sciences, 1987
• Endocrine, Gastrointestinal, and Antitumor Activity of Somatostatin Analogues
  Published by Springer Nature ,1986
• Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent Cancers
  Experimental Biology and Medicine, 1984
• Physiological Concentrations of Prolactin Can Promote the Growth of Human Breast Tumor Cells in Culture*
  Journal of Clinical Endocrinology & Metabolism, 1983
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982
• Hypothalamic Regulatory Hormones
  Annual Review of Biochemistry, 1978